Evidence for Posttranscriptional Regulation of C/EBPalpha and C/EBPbeta Isoform Expression During the Lipopolysaccharide-mediated Acute-phase Response
Overview
Affiliations
The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPalpha and C/EBPbeta) serve as templates for the differential translation of several isoforms which have specific transcriptional regulatory functions. By using an oligonucleotide corresponding to the C/EBP binding site of the mouse alpha1-acid glycoprotein promoter, we detected multiple forms of C/EBPalpha and C/EBP++ beta proteins in the mouse liver that have DNA-binding activity. By using specific antisera, we detected C/EBPalphas with molecular masses of 42, 38, 30, and 20 kDa that have DNA-binding activity. The pool levels of the 42- and 30-kDa isoforms were high in control nuclear extracts and decreased significantly after lipopolysaccharide (LPS) treatment. The binding activity and protein levels of the 20-kDa isoform are low in controls and increase dramatically after LPS treatment. C/EBPbeta isoforms with molecular masses of 35, 20, and 16 kDa were also detected. The 35-kDa pool level did not change whereas the 20-kDa isoform was strongly induced in response to LPS. Western (immunoblot) and Southwestern (DNA-protein) analyses show that p42 C/EBPalpha forms specific complexes with the alpha1-acid glycoprotein oligonucleotide in control nuclear extract and that p20 C/EBP beta forms complexes in LPS-treated liver. Our studies suggest that synthesis of specific C/EBPalpha and C/EBPbeta isoforms occurred in the normal liver in vivo and that LPS mediated a differential initiation and inhibition of translation at specific AUG sites within each mRNA. The qualitative and quantitative changes in C/EBPalpha and C/EBPbeta isoform pool levels suggest that LPS or an LPS-stimulated factor can regulate the selection of AUG start sites for both activation and repression of translation. This regulation appears to involve an LPS-mediated down-regulation of initiation at the first AUG codon of the 42-kDa C/EBPalpha and dramatic translational up-regulation at the fifth AUG codon of the 20-kDa C/EBPalpha and the third AUG codon of the 20-kDa C/EBPbeta. These regulatory events suggest the existence of proteins that may act as translational trans-acting factors.
The Role of CYP3A in Health and Disease.
Klyushova L, Perepechaeva M, Grishanova A Biomedicines. 2022; 10(11).
PMID: 36359206 PMC: 9687714. DOI: 10.3390/biomedicines10112686.
Aggarwal N, Yadav J, Thakur K, Bibban R, Chhokar A, Tripathi T Front Cell Infect Microbiol. 2020; 10:537650.
PMID: 33344262 PMC: 7738612. DOI: 10.3389/fcimb.2020.537650.
Muruganandan S, Ionescu A, Sinal C Int J Mol Sci. 2020; 21(7).
PMID: 32224846 PMC: 7177886. DOI: 10.3390/ijms21072277.
Mallick P, Taneja G, Moorthy B, Ghose R Expert Opin Drug Metab Toxicol. 2017; 13(6):605-616.
PMID: 28537216 PMC: 5714652. DOI: 10.1080/17425255.2017.1292251.
Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L Oncotarget. 2015; 6(18):16106-19.
PMID: 25965830 PMC: 4599259. DOI: 10.18632/oncotarget.3867.